Its interaction with ITGAV further underscores the potential of ITGAV in cancer therapy, highlighting that by targeting the molecules it interacts with, drug efficacy could be enhanced or new therapeutic pathways may be explored. The gene discussed is ITGAV; the disease is cancer.